The Safety and Efficacy Study of HU-014 Versus Botox® in Subject With Moderate to Severe Glabellar Lines
NCT02961673 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 57
Last updated 2018-04-12
Summary
A Phase I/Ⅱ Clinical Trial to Compare the Safety and Efficacy of HU-014 versus Botox® in Subject with Moderate to Severe Glabellar Lines
Conditions
- Glabellar Lines
Interventions
- BIOLOGICAL
-
HU-014 Inj
Clostridium botulinum type A
- BIOLOGICAL
-
Botox Inj
Clostridium botulinum type A
Sponsors & Collaborators
-
Huons Co., Ltd.
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-09-30
- Primary Completion
- 2017-02-28
- Completion
- 2017-03-31
Countries
- South Korea
Study Locations
More Related Trials
-
To Evaluate the Safety and Efficacy of Botulax® Are Not Inferior to Those of Botox® in the Treatment of Glabellar Lines
NCT01791920 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment of Moderate to Severe Glabellar Lines (BMI2006)
NCT05531968 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of Botulinum Toxin for the Treatment of Glabellar Frown Lines
NCT02236312 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of DWP450 Compared With Botox in Moderate to Severe Glabellar Line
NCT01629875 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of ATGC-100 for the Treatment of Moderate to Severe Glabellar Lines in Adult Subjects
NCT03970876 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Phase II Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Moderate to Severe Glabellar Lines
NCT05217355 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Evaluate the Efficacy and Safety of MBA-P01 in Subjects With Glabellar Lines
NCT05059587 ·Status: COMPLETED ·Phase: PHASE3
-
The Treatment of Glabellar Frown Lines
NCT02096081 ·Status: COMPLETED ·Phase: PHASE4
-
A Study to Evaluate the Efficacy and Safety of QM1114-DP for the Treatment of Moderate to Severe Glabellar Lines
NCT05463965 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluate the Safety and Explore the Efficacy of DWP712 With Moderate to Severe Glabellar Lines
NCT06212960 ·Status: COMPLETED ·Phase: PHASE1
-
Botulinum Toxin Treatment of Glabellar Lines: Efficacy and Safety Study I
NCT02677298 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Trial to Evaluate the Efficacy and Safety of MBA-P01 in Treatment of Glabellar Lines
NCT04143815 ·Status: COMPLETED ·Phase: PHASE2
-
Subject Satisfaction With AbobutulinumtoxinA Treatment
NCT03687736 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines in Phase 3 Trial
NCT05804656 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Crows Feet) in Subjects With Moderate to Severe Upper Facial Lines
NCT04622254 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety Study of Botulinum Toxin Type A to Treat Glabellar Lines
NCT01237977 ·Status: COMPLETED ·Phase: PHASE3
-
The Efficacy and Safety of Protoxin in Subjects With Moderate to Severe Glabellar Lines
NCT06124794 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase 3 Clinical Study to Evaluate the Efficacy and Safety of Botulinum Toxin Type A for Injection (CU-20101)
NCT06585696 ·Status: COMPLETED ·Phase: PHASE3
-
Long-term Treatment of Moderate to Severe Glabellar Lines and Lateral Canthal Lines
NCT04225260 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of the Simultaneous Treatment of Upper Facial Lines (Horizontal Forehead Lines, Glabellar Frown Lines and Lateral Canthal Lines) in Subjects With Moderate to Severe Upper Facial Lines
NCT04594213 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy Study of PurTox® Botulinum Toxin Type A to Treat Frown Lines Between the Eyebrows
NCT00752297 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of CKDB-501A in Subjects With Moderate-to-severe Glabellar Lines
NCT05292638 ·Status: COMPLETED ·Phase: PHASE1
-
Evaluate the Safety and Efficacy of Botulax® as Compared to Botox® in Subject With Moderate to Severe Crow's Feet Lines
NCT03408236 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of AbobotulinumtoxinA for the Treatment of Glabellar Lines
NCT03736928 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluate the Efficacy and Safety of DWP712 With Moderate to Severe Glabellar Lines
NCT07013279 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3